Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald de Wit

Showing results (11-20 of 204) with videos related to

Pageof 21
Sort By:
Cancer|April 4, 2003
Overview of bladder cancer trials in the European Organization for Research and TreatmentRonald de Wit,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Primum Non Nocere: Of Course! But How?Jan Oldenburg, Ronald de Wit
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Controversies in the management of clinical stage I testis cancerRonald de Wit, Karim Fizazi
Critical Reviews in Oncology/Hematology|February 27, 2003
Overview of gemcitabine triplets in metastatic bladder cancerRonald de Wit, Joaquim Bellmunt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Optimal management of clinical stage I testis cancer: one size does not fit allRonald de Wit, George J Bosl
European Urology|August 6, 2013
Taxane mechanisms of action: potential implications for treatment sequencing in metastatic castration-resistant prostate cancerJohn M Fitzpatrick, Ronald de Wit
Seminars in Urologic Oncology|August 29, 2002
Editorial: the coming revolution in the treatment of prostate cancer patientsDaniel P Petrylak, Ronald de Wit
European Urology|November 21, 2020
Use of Chemotherapy and Androgen Signaling-targeted Inhibitors in Patients with Metastatic Prostate CancerRonald de Wit, Bertrand Tombal, Stephen Freedland
European Urology|October 18, 2016
Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033Robert J van Soest, Ronald de Wit
European Urology|August 22, 2016
Prostate Cancer and Immune Monitoring: Are We Heading Towards Better Selection of Patients and Treatment Strategies?Martijn Lolkema, Reno Debets, Ronald de Wit
Pageof 21

Showing results (11-20 of 204) with videos related to

Sort By:
Pageof 21
Cancer|April 4, 2003
Overview of bladder cancer trials in the European Organization for Research and TreatmentRonald de Wit,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Primum Non Nocere: Of Course! But How?Jan Oldenburg, Ronald de Wit
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Controversies in the management of clinical stage I testis cancerRonald de Wit, Karim Fizazi
Critical Reviews in Oncology/Hematology|February 27, 2003
Overview of gemcitabine triplets in metastatic bladder cancerRonald de Wit, Joaquim Bellmunt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Optimal management of clinical stage I testis cancer: one size does not fit allRonald de Wit, George J Bosl
European Urology|August 6, 2013
Taxane mechanisms of action: potential implications for treatment sequencing in metastatic castration-resistant prostate cancerJohn M Fitzpatrick, Ronald de Wit
Seminars in Urologic Oncology|August 29, 2002
Editorial: the coming revolution in the treatment of prostate cancer patientsDaniel P Petrylak, Ronald de Wit
European Urology|November 21, 2020
Use of Chemotherapy and Androgen Signaling-targeted Inhibitors in Patients with Metastatic Prostate CancerRonald de Wit, Bertrand Tombal, Stephen Freedland
European Urology|October 18, 2016
Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033Robert J van Soest, Ronald de Wit
European Urology|August 22, 2016
Prostate Cancer and Immune Monitoring: Are We Heading Towards Better Selection of Patients and Treatment Strategies?Martijn Lolkema, Reno Debets, Ronald de Wit
Pageof 21